Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata
Launched by CAIRO UNIVERSITY · May 22, 2018
Trial Information
Current as of June 23, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients presenting with scalp alopecia areata, patchy type, of at least 2 months duration.
- Exclusion Criteria:
- • Alopecia totalis and alopecia universalis.
- • Alopecia areata solely affecting the beard.
- • Pregnant and lactating.
- • Patients known to have autoimmune diseases e.g. autoimmune thyroid disease, vitiligo or SLE.
- • Patients receiving systemic treatment relevant to alopecia areata within 3 months before enrollment into the study or topical treatment relevant to alopecia areata within 2 months before.
- • Patients with a dermatological condition affecting the scalp other than AA: e.g. psoriasis, eczema.
- • Patients with psychiatric illness or psychological state interfering with compliance or influencing the expectation of the patient.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Nermine H El-Eishi, MD
Study Chair
Cairo University
Heba M Mashaly, MD
Principal Investigator
Cairo University
Solwan I El-Samanoudy, MD
Principal Investigator
Cairo University
Mona MI ElKalioby, MD
Principal Investigator
Cairo University
Olfat G Shaker, MD
Principal Investigator
Cairo University
Rania M Abdel-Hay, MD
Principal Investigator
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials